Arbor Biotechnologies Appoints Mathew Pletcher, Ph.D., as Chief Scientific Officer

CAMBRIDGE, MA – May 18, 2026 – Arbor Biotechnologies, Inc., a biotechnology company discovering and developing the next generation of genetic medicines, today announced the appointment of Mathew Pletcher, Ph.D., as Chief Scientific Officer, succeeding John Murphy, Ph.D., who is retiring after five Read More The post Arbor Biotechnologies Appoints Mathew Pletcher, Ph.D., as Chief Scientific Officer appeared first on Arbor Biotechnologies .